Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laurie Keating Insider Profile
4 Followers
Laurie Keating, EVP, Chief Legal Officer at Alnylam Pharma, holds 4.17K shares in PepGen Inc. (Ticker: PEPG), holds 14.00K shares in Immuneering (Ticker: IMRX), holds 5.57K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Laurie Keating Bought ― shares of PepGen Inc. on Jan 19, 2023 for an estimated value of 49.99K.
Laurie Keating Alnylam Pharma (ALNY)EVP, Chief Legal Officer
Alnylam Pharma (ALNY)
EVP, Chief Legal Officer
Ranked #74,008 out of 98,564 Corporate Insiders
Profitable Transactions
2 out of 6 Profitable Transactions
Average Return
-14.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Laurie Keating holds in companies
Most Profitable Insider Trade
The most profitable trade made by Laurie Keating
Laurie Keating's Trading History
Alnylam Pharma
Aug 09, 2021
EVP, Chief Legal Officer
Uninformative Sell
1.89M
$813.03K
Immuneering
May 17, 2022
Director
Informative Buy
35.00K
$22.82K
Imago BioSciences
―
―
―
―
PepGen Inc.
Jan 19, 2023
Director
Informative Buy
49.99K
$48.83K
List of latest transactions for each holding click on a transaction to see Laurie Keating's performance on stock
You May Also Like
Laurie Keating insider profile FAQ
What is the percentage of profitable transactions made by Laurie Keating?
The percentage of profitable transactions made by Laurie Keating is 33%.
What is the average return per transaction made by Laurie Keating?
The average return per transaction made by Laurie Keating is -14.00%.
What stocks does Laurie Keating hold?
Laurie Keating holds: ALNY, IMRX, IMGO, PEPG stocks.
What was Laurie Keating’s latest transaction?
Laurie Keating latest transaction was an Informative Buy of $49.99K.
What was Laurie Keating's most profitable transaction?
Laurie Keating’s most profitable transaction was an Informative Buy of IMRX stock on May 17, 2022. The return on the trade was 71.10%.
What is Laurie Keating's role in Alnylam Pharma?
Laurie Keating's role in Alnylam Pharma is EVP, Chief Legal Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.